PreprintCited by 5Liver physiology and pathologyLiver Disease Diagnosis and TreatmentDrug-Induced Hepatotoxicity and Protection

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Screening the human druggable genome identifies ABHD17B as an anti-fibrotic target in hepatic stellate cells

Open access

Preprint — published as 10.1038/s41467-025-56900-z · Paper page

Abstract

Hepatic stellate cells (HSCs) are activated with chronic liver injury and transdifferentiate into myofibroblasts, which produce excessive extracellular matrices that form the fibrotic scar. While the progression of fibrosis is understood to be the cause of end-stage liver disease, there are no approved therapies directed at interfering with the activity of HSC myofibroblasts. We performed a high-throughput small interfering RNA (siRNA) screen in primary human HSC myofibroblasts to identify gene products necessary for the fibrotic phenotype of HSCs. We found that depletion of ABHD17B promotes the inactivation of HSCs, characterized by reduced COL1A1 and ACTA2 expression and accumulation of lipid droplets. Mice deficient for Abhd17b are also protected from fibrosis in the setting of in vivo liver injury. While ABHD17B is a depalmitoylase, our data suggest that ABHD17B promotes fibrosis through pathways independent of depalmitoylation that include interaction with MYO1B to modulate gene expression and HSC migration. Together, our results provide an analysis of the phenotypic consequences for siRNAs targeting RNAs from >9,500 genes in primary human HSCs and identify ABHD17B as a potential therapeutic target to inhibit liver fibrosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2023.08.07.551744

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 62

  1. 10.1053/gast.2002.33023 · DOI
  2. 10.1002/hep.23623 · DOI
  3. 10.1016/j.jhep.2017.07.022 · DOI · Paper page
  4. 10.1073/pnas.82.24.8681 · DOI · Paper page
  5. 10.1172/JCI114886 · DOI
  6. 2013, Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology, Nature Communications, 4, 1
  7. 2008, Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver, 88, 125
  8. 10.1172/JCI200524282 · DOI · Paper page
  9. 10.1002/hep.21260 · DOI
  10. 10.1073/pnas.1201840109 · DOI · Paper page
  11. 10.1053/j.gastro.2012.06.036 · DOI · Paper page
  12. 2017, Tricyclic Antidepressants Promote Ceramide Accumulation to Regulate Collagen Production in Human Hepatic Stellate Cells, Scientific Reports, 7, 44867, 10.1038/srep44867 · DOI
  13. 2022, Nanchangmycin regulates FYN, PTK2, and MAPK1/3 to control the fibrotic activity of human hepatic stellate cells, Elife, 11, e74513, 10.7554/eLife.74513 · DOI
  14. 2014, Automation Considerations for RNAi Library Formatting and High Throughput Transfection. eBook. eISBN 978-1-60805-940-9, Frontiers in RNAi, 1, 21
  15. 10.1186/s13073-016-0285-0 · DOI
  16. 10.1002/hep.31987 · DOI · Paper page
  17. 10.1073/pnas.96.5.2345 · DOI
  18. 10.1016/S0016-5085(03)00666-8 · DOI
  19. 10.1006/bbrc.1997.7892 · DOI
  20. 10.7554/eLife.11306 · DOI
  21. 10.1084/jem.20110551 · DOI
  22. 10.1021/acscatal.5b01539 · DOI
  23. 10.1038/s41589-021-00785-8 · DOI
  24. 2021, AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models, Nucleic Acids Res, 50, D439
  25. 10.1002/jcc.20292 · DOI
  26. 10.1016/0263-7855(96)00018-5 · DOI · Paper page
  27. 10.1002/jcc.20289 · DOI · Paper page
  28. 10.1038/nmeth.1293 · DOI
  29. 10.1038/ncb2262 · DOI
  30. 10.1016/j.jhep.2017.07.027 · DOI · Paper page
  31. 10.1056/NEJM200102083440610 · DOI
  32. 10.1056/NEJMoa0907929 · DOI · Paper page
  33. 2022, HK1 from hepatic stellate cell–derived extracellular vesicles promotes progression of hepatocellular carcinoma, Nat. Metab, 4, 1306, 10.1038/s42255-022-00642-5 · DOI
  34. 10.1152/ajpgi.00105.2021 · DOI
  35. 10.1093/emboj/17.10.2855 · DOI
  36. 10.1016/j.cell.2007.11.042 · DOI
  37. 2019, Exogenous expression of caveolin-1 is sufficient for hepatic stellate cell activation, J. Cell. Biochem, 120, 19031, 10.1002/jcb.29226 · DOI
  38. 10.1074/jbc.M201083200 · DOI
  39. 1993, Specific binding of heterogeneous ribonucleoprotein particle protein K to the human c-myc promoter, in vitro, J Biol Chem, 268, 18249, 10.1016/S0021-9258(17)46837-2 · DOI
  40. 10.1002/jcb.20486 · DOI
  41. 10.1136/gut.50.4.571 · DOI · Paper page
  42. 10.1016/j.cub.2014.11.054 · DOI
  43. Liu, J. et al. Stk38 Modulates Rbm24 Protein Stability to Regulate Sarcomere Assembly in Cardiomyocytes. Sci Rep-uk 7, 44870 (2017). · DOI
  44. 10.1016/0014-4827(91)90556-A · DOI
  45. 10.1126/science.1159419 · DOI
  46. 10.1073/pnas.1207811109 · DOI
  47. 10.1091/mbc.10.5.1477 · DOI
  48. 10.1242/jcs.097212 · DOI
  49. 10.1038/nature01246 · DOI
  50. 2016, Purinergic receptor X7 mediates leptin induced GLUT4 function in stellate cells in nonalcoholic steatohepatitis, Biochim. Biophys. Acta (BBA) - Mol. Basis Dis, 1862, 32, 10.1016/j.bbadis.2015.10.009 · DOI
  51. 10.1002/cbic.201700693 · DOI
  52. 2019, Roles of Myosin-Mediated Membrane Trafficking in TGF-β Signaling, Int. J. Mol. Sci, 20, 3913, 10.3390/ijms20163913 · DOI
  53. 10.1126/scitranslmed.aay8798 · DOI · Paper page
  54. 2001, Fibroblasts from Idiopathic Pulmonary Fibrosis and Normal Lungs Differ in Growth Rate, Apoptosis, and Tissue Inhibitor of Metalloproteinases Expression. Am J Resp Cell Mol, 24, 591
  55. 2019, Primary cell-based phenotypic assays to pharmacologically and genetically study fibrotic diseases in vitro, J Biological Methods, 6, e115
  56. 2020, Rapid purification and metabolomic profiling of synaptic vesicles from mammalian brain, Elife, 9, e59699, 10.7554/eLife.59699 · DOI
  57. Love, M. I. , Huber, W. & Anders, S . Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15, 550 (2014). · DOI · Paper page
  58. 10.1038/nmeth.3213 · DOI · Paper page
  59. 10.1002/jcc.20945 · DOI · Paper page
  60. 2020, An Allosteric Binding Site on Sortilin Regulates the Trafficking of VLDL, PCSK9, and LDLR in Hepatocytes, Biochemistry, 59, 4321, 10.1021/acs.biochem.0c00741 · DOI
  61. 10.1038/nmeth.4067 · DOI
  62. 10.1186/1471-2105-9-40 · DOI · Paper page

Metadata

Authors
Li, W., Sparks, R. P., Sun, C., Yang, Y., Pantano, L., Kirchner, R., Weilheimer, A., Toles, B. J., Chen, J. Y., Moran, S. P., Barrera, V., Li, Z., Zhou, P., Brassil, M. L., Wrobel, D., Sui, S. J. H., Aspnes, G., Schuler, M., Smith, J., Medoff, B. D., Zhou, C., Boustany-Kari, C. M., Rippmann, J. F., Santos, D. M., Doerner, J. F., & Mullen, A. C.
Affiliations
  • Harvard University (US)
  • University of Massachusetts Chan Medical School (US)
  • Boehringer Ingelheim (Germany) (DE)
  • Broad Institute (US)
Corresponding author
Mullen, Alan C.
Venue
Nature Communications
Publisher
openRxiv
Published
2023-08-07
Volume
16
Issue
1
Pages
2109-2109
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4408080607
Cited by
5
References
1
Citations by year
2026: 3 · 2025: 2
FWCI
2.78
Type
journal article
Language
en
Open access
Locations
  • Nature Communications (publishedVersion, cc-by-nc-nd)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Boehringer Ingelheim
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords
hepatic stellate cells, liver fibrosis, myofibroblast transdifferentiation, depalmitoylation, MYO1B, lipid droplets, COL1A1, ACTA2, HSC migration, siRNA screen
MeSH terms
Collagen Type I, alpha 1 Chain, Actins, Animals, Cell Movement, Humans, Liver, Liver Cirrhosis, Male, Mice, Inbred C57BL, Mice, Knockout, Collagen Type I, RNA, Small Interfering, Mice, Hepatic Stellate Cells, Myofibroblasts, Lipid Droplets

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review